Somatostatin receptor ligands and resistance to treatment in pituitary adenomas
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Somatostatin receptor ligands and resistance to treatment in pituitary adenomas
Authors
Keywords
-
Journal
JOURNAL OF MOLECULAR ENDOCRINOLOGY
Volume 52, Issue 3, Pages R223-R240
Publisher
Bioscientifica
Online
2014-03-20
DOI
10.1530/jme-14-0011
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Expert consensus document: A consensus on the medical treatment of acromegaly
- (2014) Andrea Giustina et al. Nature Reviews Endocrinology
- Constitutive Somatostatin Receptor Subtype 2 Activity Attenuates GH Synthesis
- (2013) Anat Ben-Shlomo et al. ENDOCRINOLOGY
- β-Arrestin 1 and 2 and G Protein-Coupled Receptor Kinase 2 Expression in Pituitary Adenomas: Role in the Regulation of Response to Somatostatin Analogue Treatment in Patients With Acromegaly
- (2013) Federico Gatto et al. ENDOCRINOLOGY
- Preoperative Normalization of Cortisol Levels in Cushing's Disease After Medical Treatment: Consequences for Somatostatin and Dopamine Receptor Subtype Expression and In Vitro Response to Somatostatin Analogs and Dopamine Agonists
- (2013) R. van der Pas et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- New avenues in the medical treatment of Cushing’s disease: corticotroph tumor targeted therapy
- (2013) Maria Fleseriu et al. JOURNAL OF NEURO-ONCOLOGY
- ZAC1 and SSTR2 Are Downregulated in Non-Functioning Pituitary Adenomas but Not in somatotropinomas
- (2013) Leonardo Vieria Neto et al. PLoS One
- The role of combination medical therapy in acromegaly
- (2013) Maria Fleseriu Current Opinion in Endocrinology Diabetes and Obesity
- Oral Octreotide Absorption in Human Subjects: Comparable Pharmacokinetics to Parenteral Octreotide and Effective Growth Hormone Suppression
- (2012) S. Tuvia et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Medical Management of Persistent and Recurrent Cushing Disease
- (2012) Maria Fleseriu NEUROSURGERY CLINICS OF NORTH AMERICA
- A 12-Month Phase 3 Study of Pasireotide in Cushing's Disease
- (2012) Annamaria Colao et al. NEW ENGLAND JOURNAL OF MEDICINE
- Medical management of Cushing’s disease: what is the future?
- (2012) Maria Fleseriu et al. Pituitary
- Remission rate after transsphenoidal surgery in patients with pathologically confirmed Cushing’s disease, the role of cortisol, ACTH assessment and immediate reoperation: a large single center experience
- (2012) Nadia Hameed et al. Pituitary
- Growth hormone granulation pattern and somatostatin receptor subtype 2A correlate with postoperative somatostatin receptor ligand response in acromegaly: a large single center experience
- (2012) Jessica Brzana et al. Pituitary
- Meta-Analysis on the Effects of Octreotide on Tumor Mass in Acromegaly
- (2012) Andrea Giustina et al. PLoS One
- Novel pathway for somatostatin analogs in patients with acromegaly
- (2012) Mônica R. Gadelha et al. TRENDS IN ENDOCRINOLOGY AND METABOLISM
- Balance between somatostatin and D2 receptor expression drives TSH-secreting adenoma response to somatostatin analogues and dopastatins
- (2011) Federico Gatto et al. CLINICAL ENDOCRINOLOGY
- Intensity of pituitary adenoma on T2-weighted magnetic resonance imaging predicts the response to octreotide treatment in newly diagnosed acromegaly
- (2011) Ansgar Heck et al. CLINICAL ENDOCRINOLOGY
- Resistance to Somatostatin Analogs in Acromegaly
- (2011) Annamaria Colao et al. ENDOCRINE REVIEWS
- Homologous and Heterologousin VitroRegulation of Pituitary Receptors for Somatostatin, Growth Hormone (GH)-Releasing Hormone, and Ghrelin in a Nonhuman Primate (Papio anubis)
- (2011) Jose Córdoba-Chacón et al. ENDOCRINOLOGY
- DG3173 (somatoprim), a unique somatostatin receptor subtypes 2-, 4- and 5-selective analogue, effectively reduces GH secretion in human GH-secreting pituitary adenomas even in Octreotide non-responsive tumours
- (2011) U Plöckinger et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Somatostatin Dramatically Stimulates Growth Hormone Release from Primate Somatotrophs Acting at Low Doses Via Somatostatin Receptor 5 and Cyclic AMP
- (2011) J. Córdoba-Chacón et al. JOURNAL OF NEUROENDOCRINOLOGY
- Structural Determinants of Agonist-Selective Signaling at the sst2ASomatostatin Receptor
- (2011) Falko Nagel et al. MOLECULAR ENDOCRINOLOGY
- Effect of SOM230 (Pasireotide) on Corticotropic Cells: Action in Dogs with Cushing’s Disease
- (2011) Victor Castillo et al. NEUROENDOCRINOLOGY
- Identification and characterization of new functional truncated variants of somatostatin receptor subtype 5 in rodents
- (2010) Jose Córdoba-Chacón et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Pasireotide (SOM230) Demonstrates Efficacy and Safety in Patients with Acromegaly: A Randomized, Multicenter, Phase II Trial
- (2010) S. Petersenn et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- The Expression of E-Cadherin in Somatotroph Pituitary Adenomas Is Related to Tumor Size, Invasiveness, and Somatostatin Analog Response
- (2010) Stine Lyngvi Fougner et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- A Consensus on Criteria for Cure of Acromegaly
- (2010) A. Giustina et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- ZAC1 target genes and pituitary tumorigenesis
- (2010) Marily Theodoropoulou et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- Clinical efficacy and safety results for dose escalation of somatostatin receptor ligands in patients with acromegaly: a literature review
- (2010) Maria Fleseriu Pituitary
- Pituitary somatostatin receptor signaling
- (2010) Anat Ben-Shlomo et al. TRENDS IN ENDOCRINOLOGY AND METABOLISM
- High-dose intramuscular octreotide in patients with acromegaly inadequately controlled on conventional somatostatin analogue therapy: a randomised controlled trial
- (2009) Andrea Giustina et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Differential Ligand-Mediated Pituitary Somatostatin Receptor Subtype Signaling: Implications for Corticotroph Tumor Therapy
- (2009) Anat Ben-Shlomo et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Expression Analysis of Dopamine Receptor Subtypes in Normal Human Pituitaries, Nonfunctioning Pituitary Adenomas and Somatotropinomas, and the Association between Dopamine and Somatostatin Receptors with Clinical Response to Octreotide-LAR in Acromegaly
- (2009) Leonardo Vieira Neto et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Identification and Characterization of Two Novel Truncated but Functional Isoforms of the Somatostatin Receptor Subtype 5 Differentially Present in Pituitary Tumors
- (2009) Mario Durán-Prado et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Guidelines for Acromegaly Management: An Update
- (2009) S. Melmed et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Acromegaly pathogenesis and treatment
- (2009) Shlomo Melmed JOURNAL OF CLINICAL INVESTIGATION
- Effects of lanreotide SR and Autogel on tumor mass in patients with acromegaly: a systematic review
- (2009) Gherardo Mazziotti et al. Pituitary
- Acromegaly: correlation between expression of somatostatin receptor subtypes and response to octreotide-lar treatment
- (2009) Ana Paula M. Casarini et al. Pituitary
- Rapid and sustained reduction of serum growth hormone and insulin-like growth factor-1 in patients with acromegaly receiving lanreotide Autogel® therapy: a randomized, placebo-controlled, multicenter study with a 52 week open extension
- (2009) Shlomo Melmed et al. Pituitary
- Quantitative analysis of somatostatin receptor subtypes (1–5) gene expression levels in somatotropinomas and correlation to in vivo hormonal and tumor volume responses to treatment with octreotide LAR
- (2008) Giselle F Taboada et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- A Critical Analysis of Clinically Available Somatostatin Analog Formulations for Therapy of Acromegaly
- (2008) Robert D. Murray et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Treatment of Adrenocorticotropin-Dependent Cushing’s Syndrome: A Consensus Statement
- (2008) B. M. K. Biller et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Low Levels of Raf Kinase Inhibitory Protein in Growth Hormone-Secreting Pituitary Adenomas Correlate with Poor Response to Octreotide Treatment
- (2008) Stine Lyngvi Fougner et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Treatment of Pituitary-Dependent Cushing’s Disease with the Multireceptor Ligand Somatostatin Analog Pasireotide (SOM230): A Multicenter, Phase II Trial
- (2008) M. Boscaro et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Differential Effects of Octreotide and Pasireotide on Somatostatin Receptor Internalization and Traffickingin Vitro
- (2008) Sarah Lesche et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Differential regulation of human dopamine D2 and somatostatin receptor subtype expression by glucocorticoids in vitro
- (2008) C de Bruin et al. JOURNAL OF MOLECULAR ENDOCRINOLOGY
- Transcriptional regulation of the presenilin-1 gene: implication in Alzheimer's disease
- (2007) Hriday et al. Frontiers in Bioscience-Landmark
- Somatostatin agonists for treatment of acromegaly
- (2007) Anat Ben-Shlomo et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- Genetic abnormalities of somatostatin receptors in pituitary tumors
- (2007) A. Lania et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started